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Abstract 
 
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation 
and destruction of synovial joints. The function of sirtuin (SIRT)1 in RA is inconclusive. In 
human synovial cells SIRT1 was shown to promote cytokine production and apoptosis 
resistance. However, deletion of SIRT1 aggravated inflammatory arthritis in mice and 
increased production of pro-inflammatory cytokines in murine macrophages. In the current 
study we investigated the regulation, expression and function of SIRT1 in RA, in particular its 
role in adhesion and proliferation of human RA synovial fibroblasts (RASF). We found that 
expression of SIRT1 was increased in vivo in synovial tissues of RA smokers and in vitro by 
stimulation of RASF with TNFα, but decreased upon treatment with cigarette smoke extract. 
Synovial tissues of RA smokers showed higher leukocytic infiltration that positively 
correlated with enhanced levels of SIRT1. Global transcriptome analysis revealed that SIRT1 
modulates expression of genes involved in the regulation of inflammatory response and cell 
adhesion. In functional studies, silencing of SIRT1 reduced proliferation and leukocytic 
adhesion to RASF, but showed inconsistent results in the regulation of adhesion to plastic. In 
conclusion, SIRT1 modulates the proliferative and potentially also adhesive properties of 
RASF and can therefore promote progression of RA. 
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Introduction  
 
Rheumatoid arthritis (RA) is a chronic inflammatory disease primarily affecting synovial 
joints and leading to a progressive destruction of cartilage and bone. A combination of genetic 
predisposition, immunological deregulation and environmental factors contribute to its 
pathogenesis [1]. The most recognized environmental risk factor for the development and 
severity of RA is cigarette smoking [2-4]. RA synovium is characterized by synovial 
hyperplasia and infiltration of inflammatory cells together with high production of pro-
inflammatory cytokines such as tumor necrosis alpha (TNFα) [5]. Thus, inhibition of 
inflammatory processes is the main strategy in the treatment of RA.  
SIRTs are class III histone deacetylases that regulate the activity of histones and non-histone 
proteins by posttranslational modifications [6]. Initially, SIRTs were identified as regulators 
of cell metabolism, survival, ageing and inflammation [7]. Recent studies demonstrated that 
SIRTs are involved in the regulation of signaling pathways induced by environmental stress 
factors, such as cigarette smoking. Exposure to cigarette smoke reduced the expression of 
SIRT1 in human and rat lungs as well as in human endothelial, epithelial and monocyte-
macrophage cell lines [8-10].  
The role of SIRT1 in cancer and inflammation, in particular arthritis is controversial. 
Expression of SIRT1 was shown to be increased in the synovium of RA patients [13]. Down 
regulation of SIRT1 or inhibition of sirtuin activities in synovial cells of RA patients was 
found to reduce the expression of inflammatory mediators [13, 14], and overexpression of 
SIRT1 increased production of pro-inflammatory cytokines in rheumatoid arthritis synovial 
fibroblasts (RASF) and monocytes from healthy persons [13]. In contrast, levels of SIRT1 
were diminished in joint tissues of mice with collagen-induced arthritis [15]. Moreover, 
deletion of SIRT1 aggravated inflammatory arthritis in serum transfer arthritis model and 
increased production of pro-inflammatory cytokines in macrophages [16]. 
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In the current study we further analysed the role of SIRT1 in RA. To elucidate the function of 
SIRT1 in RA synovium we used a next generation sequencing approach to identify specific 
targets and biological processes regulated by SIRT1 in RASF. 
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Material and Methods 
 
Patient samples and cell culture 
Synovial tissues were obtained from RA patients undergoing joint replacement surgery at the 
Schulthess Clinic Zurich after obtaining informed written consent according to the principles 
of the 1964 Declaration of Helsinki. For experiments with human tissues, ethical approval 
was obtained at the Swiss Ethical commission. RA patients fulfilled the American College of 
Rheumatology criteria for the classification of RA [17]. RASF were isolated and cultured as 
described previously [18]. Cells between passages 4 to 8 were used.  
 
CSE preparation and stimulation assays 
Cigarette smoke extract (CSE) was prepared using a modification of the method described by 
Vassallo et al [19]. 100% CSE was prepared by bubbling of the smoke of one cigarette into 10 
ml of cell culture medium at a rate of one cigarette per 7 minutes. CSE was sterile filtered 
through 0.2 μm filter and diluted to 5% CSE with cell culture medium. The pH of 5% CSE 
and of the control cell culture medium was equal and remained unaltered during the 
cultivation. The cigarettes used contained 10 mg tar, 0.8 mg nicotine and 10 mg carbon 
monoxide (Marlboro Red). RASF were stimulated with 5% CSE or 10 ng/ml TNFα (R&D 
systems) for 24 hours.  
 
Overexpression and gene silencing 
RASF were transfected using the Basic Nucleofector Kit for Primary Mammalian Fibroblasts 
(Amaxa) according to the manufacturer’s instructions. In silencing experiments, 100 µM of 
validated siRNA for SIRT1 or control siRNA (Invitrogen) were used. For overexpression of 
SIRT1, 1 μg of SIRT1 wild-type or empty pcDNA3.1(-) (mock) expression vectors were used 
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as previously described [13]. Silencing and overexpression of SIRT1 were verified by 
Western blot analysis or real-time PCR (Supplementary Fig.1). 
 
RNA isolation and quantitative real-time PCR 
RNA was isolated, reverse transcribed and gene expression quantified as previously described 
[20]. Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was used as an endogenous 
control. The primer sequences used are given in the Supplementary table S1.  
 
Next generation sequencing and functional annotation analysis 
For transcriptome analysis the expression of SIRT1 was down or up regulated in RASF (n=2) 
for 72h as described above. RNA was isolated using RNeasy Plus Micro Kit (Qiagen) 
followed by treatment with RNase-free DNase (Invitrogen). RNA was cleaned-up using 
RNeasy Mini Kit (Qiagen). The library constructs were produced using TruSeq Stranded 
mRNA Sample Preparation Kit according to Illumina TruSeq® Stranded mRNA protocol. 
Libraries were pooled and further used for cluster generation using TruSeq SR Cluster Kit v3-
cBot-HS reagents and sequenced with TruSeq SBS Kit v3-HS reagents on Illumina HiSeq 
2500 in the high output mode. For pathway enrichment analysis only coding transcripts that 
were found to be altered by silencing as well as by overexpression of SIRT1 (cut-off log2 
ratio > +/-0.4) and had a signal intensity of >10 were taken into account. Functional 
annotation clustering was done using the Database for Annotation, Visualization and 
Integrated Discover (DAVID) [21, 22]. Gene Ontology (GO) terms corresponding to the 
biological processes (BP-FAT) were used to group the genes. The significance of the gene-
term enrichment was determined by Fischer`s exact test and p values ≤0.05 were considered 
strongly enriched. 
 
Proliferation and adhesion assays 
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Proliferation and adhesion of RASF were measured in the xCELLigence Real-Time Cell 
Analyzer (RTCA) DP system (Bucher Biotec AG). For proliferation assay, RASF were 
transfected with SIRT1 siRNA or control siRNA as described above and 2500 cells were 
seeded in each well. Medium was changed 24h after transfection. The rate of proliferation 
was determined by calculating the slope of the cell index (CI) curve in the interval between 40 
and 85h after transfection, since the best efficacy of SIRT1 silencing was observed 48 – 96h 
after transfection. To investigate the effect of SIRT1 on adhesion, RASF were transfected for 
72h with SIRT1 siRNA or control siRNA as described above. Cells were detached with 
accutase and 2500 cells were seeded in each well. The rate of adhesion was determined by 
calculating the slope of the CI curve between 0 and 60min after seeding of cells. 
 
Leukocyte adhesion assay 
Leukocyte adhesion to RASF was performed based on the protocol by Tessier et al.[23]. 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole EDTA blood from 
one healthy donor by Ficoll paque plus (GE Healthcare). RASF were transfected with SIRT1 
or scrambled siRNA for 72h before 1x106 PBMCs were added to 3 x 104 RASF for 1 hour. 
The wells were washed 3 times with PBS and the adherent cells were stained with 0.01% 
methylene blue, 0.05% crystal violet, 2% methanol, 3% acetic acid and 95% distilled H2O. 
PBMCs were counted in 4 visual fields (100x magnification) per condition. 
 
Immunohistochemistry 
Formalin-fixed, paraffin-embedded synovial tissues (n=23) were deparaffinised and pretreated 
with 10 mM citrate buffer (pH=6) for antigen unmasking. After washing with ddH2O, 
blocking of endogenous peroxidase activity (3% H2O2) and of non-specific binding (5% goat 
serum in antibody diluent (Dako)), slides were incubated with rabbit IgG (Jackson 
ImmunoResearch) or rabbit anti-SIRT1 antibody (E104, Abcam, #ab32441, 1:40 in antibody 
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diluent). After washing, the slides were incubated with biotinylated goat-anti-rabbit antibodies 
(Jackson ImmunoResearch, 1:500 in antibody diluent/5% human serum) and the Dako 
EnVision+ System- for horseradish peroxidase (HRP). SIRT1-positive cells were visualized 
using DAB (3.3'-Diaminobenzidin). Nuclei were counterstained with hematoxylin. The 
intensity of the SIRT1 staining in synovial tissues was evaluated by 2 independent observers, 
using a gradual scoring scale from 0 (no staining) to 4 (strong staining). For the assessment of 
synovitis in synovial tissues, thickness of lining cell layer, cellular density of synovial stroma 
and leukocytic infiltrate were semiquantitatively evaluated in hematoxilin/eosin stained 
tissues as described by Krenn et al. [24]. Patient’s characteristics are shown in Table 1. In 
slides stained for SIRT1, stromal characteristics could not be evaluated and thus the synovitis 
score comprised thickness of lining layer and infiltration only. 
 
Table 1: Characteristics of the patients. 
 
 RA smoker n=22 RA nonsmoker n=27 
Age (years, mean (range)) 55 (33-80) 61 (31-78) 
Sex (female/male) 17/5 22/5 
Disease duration (years, mean (range)) 21 (4-48); 1 ND 20 (4-48); 3 ND 
number of cigarettes per day (mean 
(range)) 
15 (3-40)  
RF positiv/negative 14/3; 5 ND 14/3; 10 ND 
Medications    
        DMARDs 14 15 
        NSAIDs 13 13 
        steroids 12 11 
        biologics 2 10 
 
ND = not determined; DMARDs = disease modifying anti-rheumatic drugs; NSAIDs = non steroidal anti-
inflammatory drugs 
 
Immunoblotting 
Whole cell lysates were prepared by lysing the cells in Laemmli buffer. Proteins were 
separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis and transferred to 
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nitrocellulose membranes. Membranes were blocked with 5% milk in TBS-T and incubated 
over night at 4°C with mouse anti-proliferating cell nuclear antigen (PCNA) (PC10, Novus 
Biologicals #NB500-106, 1:1000), mouse anti-tubulin (DM1A, Abcam, # ab7291, 1:10’000), 
rabbit anti-SIRT1 (E104, Abcam, #ab32441, 1:500) or mouse anti-Vimentin antibodies 
(Abcam, #ab7752, 1:1000) in 5% milk.HRP-labeled species specific secondary antibodies 
(Jackson ImmunoResearch, 1:10000) and enhanced chemiluminescence (GE Healthcare) were 
used for visualization. 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism 5.0 software. Values are presented 
as mean±SEM. Data were analyzed using t-test or Wilcoxon Signed Rank Test as indicated. 
Correlation of SIRT1 expression with levels of synovitis or infiltration was investigated using 
Spearman correlation. P-values <0.05 were considered significant. 
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Results 
Regulation of SIRT1 expression in RASF and synovial tissues 
Smoking and TNFα are critical factors in the pathogenesis of RA. To investigate the 
regulation of SIRT1 in RASF, we stimulated the cells with 5% CSE or 10 ng/ml TNFα for 
24h. Western blot analysis revealed decreased protein levels of SIRT1 in RASF stimulated 
with CSE (Figure 1a). Opposite to CSE, stimulation of RASF with TNFα increased protein 
expression of SIRT1 (Figure 1a). Co-stimulation with CSE and TNFα together increased the 
protein levels of SIRT1 indicating that up regulation of SIRT1 by TNFα is dominant over 
down regulation of SIRT1 after CSE (Figure 1c). To analyze the effect of smoking on SIRT1 
expression in vivo, we compared the expression of SIRT1 in synovial tissue sections from RA 
smokers with RA nonsmokers by immunohistochemistry. Scoring of SIRT1 staining 
intensities revealed increased expression of SIRT1 in synovial tissues of RA smokers when 
compared to RA nonsmokers (Figures 1c, d).  
When expression of SIRT1 in synovial tissues was compared to the degree of synovitis a 
positive correlation (p=0.008) was observed (Figure 2a). By separately analyzing the two 
components of the synovitis score, namely leukocytic infiltration and thickening of the 
synovial lining layer, a significant positive correlation between the expression of SIRT1 and 
leukocytic infiltration was seen (p=0.01), while no correlation was found between SIRT1 
levels and synovial thickening (Figure 2a). Assessment of synovitis in smoking and 
nonsmoking RA patients showed that smoking RA patients had significantly higher synovitis 
score and more inflammatory cells infiltrating the synovial tissue compared to nonsmoking 
RA patients. Moreover, the density of synovial stroma was increased in smoking RA patients 
(Figure 2b). 
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Targets and biological processes regulated by SIRT1 in RASF 
To investigate the effect of increased SIRT1 expression in RA synovial tissues and RASF, as 
shown previously by Niederer et al [13], and the particular high levels of SIRT1 in RA 
smokers observed in this study, a next generation sequencing approach was applied. The 
expression of SIRT1 was decreased by SIRT1 silencing or increased by SIRT1 
overexpression and changes in gene expression were measured by poly-A-enriched 
transcriptome sequencing. 46 genes were up regulated by SIRT1 overexpression and down 
regulated by SIRT1 silencing, whereas 52 genes were down regulated after SIRT1 
overexpression and up regulated in SIRT1 silenced RASF (Figure 3, Supplementary  table 
S2). To identify the biological processes affected, we grouped the genes into specific 
biological processes using the GO annotation program DAVID. After grouping the genes that 
were up regulated by SIRT1 overexpression and down regulated by SIRT1 silencing we found 
that the top 5 biological processes with the highest numbers of enriched genes are ‘response to 
organic substance’, ‘defense response’, ‘cell adhesion’, ‘biological adhesion’ and 
‘inflammatory response’ (Supplementary table S2). Grouping of genes that were down 
regulated by SIRT1 overexpression and up regulated by SIRT1 silencing revealed that the top 
3 enriched biological processes are ‘response to wounding’, ‘defense response’ and 
‘inflammatory response’ (Supplementary table S3). Taken together, modifications of SIRT1 
levels induced strongest changes in the expression of genes involved in the regulation of 
inflammation and cell adhesion.  
Verification of SIRT1 targets that might play an important role in the pathogenesis of 
RA in more patients confirmed increased expression of Cadherin 4 (CDH4) by silencing of 
SIRT1 (Figure 4a), whereas levels of Chemokine (C-X3-C motif) ligand 1 (CX3CL1) and of 
JunB proto-oncogene (JunB) were significantly up regulated by overexpression of SIRT1 
(Figures 4b, c). 
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Effect of SIRT1 on adhesion and proliferation of RASF 
Even though not reaching statistical significance (p=0.054), adhesion was found to be one 
of the top enriched biological processes in the functional annotation analysis of SIRT1 target 
genes. Therefore we investigated the effects of SIRT1 silencing on the regulation of cell 
adhesion. Expression of SIRT1 in RASF was reduced by silencing of SIRT1 with siRNA, and 
cell behavior was monitored using the xCELLigence RTCA system. Strongest changes in 
adhesion of RASF were detected in the first 60 minutes after seeding. Therefore the slope of 
the curve between 0 and 60 min was calculated and used as a parameter for changes in cell 
adhesion. While in 3 out of 5 patients adhesion was stronger in SIRT1 siRNA than control 
siRNA transfected cells, in two patients this effect of SIRT1 silencing on adhesion was not 
seen (Figures 5a,b). Taking all patients together no significance was reached (Figure 5c). 
The chemokine CX3CL1 and the receptor stabilin-2 (STAB2) were listed in the adhesion 
pathways as well as in inflammatory pathways (‘defense response’ and ‘regulation of 
inflammatory response’). Both of these genes were implicated in the adhesion of leukocytes 
to endothelial cells [25, 26]. Therefore we incubated PBMCs with RASF that were silenced 
for SIRT1 and control transfected RASF, respectively, for 1 hour. After washing, significantly 
less PBMCs were attached to SIRT1 silenced RASF than to the control transfected RASF 
(Figure 5d). 
SIRT1 was also shown to regulate cell proliferation [27-32]. Altered proliferation of synovial 
cells was suggested to contribute to the synovial hyperplasia in RA [33]. To study the effect 
of SIRT1 on proliferation, RASF were seeded immediately after transfection with SIRT1 
siRNA and the cell behavior was monitored in real-time over a period of 160 hours using the 
xCELLigence RTCA system. Proliferation rate of RASF transfected with SIRT1 siRNA was 
significantly lower than in control transfected cells 40 – 85 hours after transfection (Figure 
6b). After around a week of growth the cell index reached the same index in SIRT1 silenced 
RASF as in control transfected cells indicating that SIRT1 silencing specifically affected 
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proliferation and not the apoptosis where the cell index would constantly decrease over time 
(Figure 6a). To confirm an effect of SIRT1 on proliferation we measured levels of PCNA 72h 
after silencing of SIRT1. PCNA levels were significantly lower in SIRT1 siRNA transfected 
cells compared to control transfected RASF (Figure 6c).  
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Discussion 
In the current study we investigated the regulation and function of SIRT1 in RA synovium. 
We found that expression of SIRT1 in vitro is differentially regulated by TNFα and CSE 
exposure in RASF. Expression of SIRT1 protein in vitro was down regulated by stimulation 
of RASF with CSE, whereas treatment with TNFα increased protein levels of SIRT1. At the 
mRNA level we previously found that the expression of SIRT1 transcript is not affected by 
stimulation with CSE [34] whereas TNFα stimulation up regulated the levels of SIRT1 
mRNA [13]. We studied the regulation of SIRT1 protein in vivo and found that SIRT1 levels 
were up regulated in the synovial tissues of RA smokers and correlated positively with 
increased leukocytic infiltration. Previously, it was shown that smokers respond less to 
therapies with disease modifying anti-rheumatic drugs and had higher levels of the chemokine 
MIP-1α [35]. The same study showed that CSE induces chemotaxis in vitro. Thus, smoking 
could enhance leukocytic infiltration in synovial tissues. This can lead to higher levels of 
TNFα, which up regulates the expression of SIRT1 in the joints of RA smokers. Indeed, 
smoking was shown to increase the levels of TNFα in the serum [36]. Moreover, release of 
TNFα by stimulated T lymphocytes was significantly higher in RA patients who smoked than 
in those who never smoked [37]. These results are in line with clinical studies showing that 
RA smokers show a poor response to anti-TNF treatment and RA heavy smokers have the 
poorest drug survival [38]. At the cellular level, exposure to cigarette smoke was also shown 
to increase the production of TNFα in inflammatory cells in vitro [39-41]. However, as 
reported previously we could not detect TNFα expression in unstimulated or CSE treated 
RASF [34]. Since cigarette smoke does not induce TNFα in RASF, the expression of SIRT1 
in RASF in vitro is regulated by CSE only, whereas in vivo increased levels of TNFα in the 
synovium of RA patients could overlap the effect of smoking resulting in up regulation of 
SIRT1 levels. Accordingly levels of SIRT1 were increased in RASF stimulated with TNFα 
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and CSE in combination, which points to a stronger effect of TNFα than CSE in the 
regulation of SIRT1.  
SIRT1 is a multifunctional protein that regulates a variety of cellular processes including cell 
survival, metabolism, ageing, inflammation and cancerogenesis in different cell types and 
tissues [7, 42]. To investigate the target genes and biological processes regulated by SIRT1 in 
RASF, we silenced or overexpressed SIRT1 and found that modifications of SIRT1 levels 
induce changes in the expression of genes involved in the regulation of inflammation and cell 
adhesion. The function of SIRT1 in inflammation is controversial. SIRT1 was shown to 
regulate many anti-inflammatory processes, but also some pro-inflammatory pathways [43, 
44]. The anti-inflammatory effect of SIRT1 and also of SIRT6, which we previously found to 
be induced by smoking, was shown to be mediated by inhibition of NF-kB-dependent gene 
expression in other cell types [34, 45, 46]. In RASF, however, we and others could show that 
SIRT6 does not affect the expression of the NF-kB dependent pro-inflammatory cytokines IL-
6 or IL-8, but reduces expression of MMP1 via direct deacetylation of the MMP1 promoter 
[34, 47]. SIRT1 on the other hand was reported to promote the production of these pro-
inflammatory cytokines in RASF and human monocytes [13]. Our results confirm the pro-
inflammatory role of SIRT1 in RASF, suggesting that neither SIRT6 nor SIRT1 negatively 
regulate NF-kB in RASF. A possible regulatory pathway in RASF might be the regulation of 
AP-1, since we found that SIRT1 enhances the expression of JunB, a component of the AP-1 
transcription factor complex, which was shown to regulate RA-associated inflammation [48]. 
We also investigated the role of SIRT1 in the regulation of cell adhesion. Despite effects of 
SIRT1 on the expression of genes involved in the regulation of adhesion (CDH4, CDH1), we 
could not detect a consistent effect of SIRT1 silencing on adhesion of RASF to the cell 
culture dish surface in functional assays. The variability in the adhesion of RASF in response 
to SIRT1 silencing could be triggered by differences in the genetic background of the patients 
or the heterogeneity of RA. Contrasting effects of SIRT1 were already reported in the 
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regulation of cancer cells. The dual role of SIRT1 in promoting or suppressing tumor 
progression was suggested to correlate with the genetic background of the tumor cells and 
with the presence or absence of p53 [11, 12]. Interestingly, p53 was shown to be 
overexpressed in RA synovium and to contribute to the regulation of synoviocyte 
invasiveness, apoptosis and proliferation [49-51]. Somatic mutations in the p53 gene were 
detected in RA synovium and were functionally linked to the regulation of inflammation [52, 
53]. Thus, depending on the expression of wild type or mutated form of p53 in RA patients 
the effect of SIRT1 in RASF could be more or less prominent. Furthermore, the transcription 
factor p53 was reported to control the transcription of CX3CL1 [54]. Therefore SIRT1-
dependent changes of CX3CL1 in RASF might be mediated via p53.  
CX3CL1 and STAB2, which were both upregulated by SIRT1, were previously described to 
increase adhesion of leukocytes to endothelial cells [25, 26]. Their downregulationmight also 
be responsible for the decreased adhesion of leukocytes to SIRT1 silenced RASF.  
Previously we could show that SIRT1 induces apoptosis in RASF [13]. Here, we found that in 
addition silencing of SIRT1 reduced the proliferation rate of RASF. Similarly, decreased 
proliferation upon silencing of SIRT1 was reported in human malignant glioma cells, 
melanoma cells, vascular smooth muscle cells and murine osteoprogenitors [27-30]. However, 
SIRT1 was also shown to inhibit proliferation in human colon cancer cells and murine gut 
epithelial cells [31, 32]. Since CX3CL1 was previously reported to increase the proliferation 
of endothelial cells [55] and we found that CX3CL1 levels are reduced by SIRT1 silencing it 
is feasible to assume that SIRT1 silencing decreases proliferation of RASF via reduction of 
CX3CL1 levels.  
In summary, our data showing that SIRT1 contributes to the activation of human synovial 
cells by promoting the pro-inflammatory, proliferative and potentially adhesive properties of 
RASF suggest an adverse function of SIRT1 in the pathogenesis of RA and are in line with 
previous reports in human cells [13, 14]. In mice, however, SIRT1 was shown to have the 
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opposite effects, since deletion of SIRT1 aggravated the inflammatory arthritis in serum 
transfer arthritis model and increased production of pro-inflammatory cytokines in murine 
macrophages [16]. Whether these different effects of SIRT1 could be species or cell type 
specific needs to be further elucidated. Thus, it is important to reconsider the influence of 
substances that modify SIRT1 activity in all cell types prior their application in murine 
models or clinical trials.  
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Figure legends 
Figure 1: Expression of SIRT1.  
a) Stimulation of RASF (n=6) with 5% CSE for 24h decreases the protein levels of SIRT1, 
but stimulation of RASF (n=10) with 10 ng/ml TNFα for 24h increased the protein levels of 
SIRT1. b) Co-stimulation of RASF with CSE and TNFα together increased the protein levels 
of SIRT1 in control transfected RASF. (c) Scoring of SIRT1 staining intensities in synovial 
tissues of RA non smokers (n=11) and RA smokers (n=12) shows increased SIRT1 levels in 
the synovium of RA smokers. (d) Representative sections of RA synovial tissues showing 
higher expression of SIRT1 (brown) in RA smokers as compared to RA non smokers. Insets 
show the control IgG staining. Nuclei were counterstained with hematoxylin (blue). Original 
magnification: ×100 (top) and×400 (bottom); scale bar = 100µm.  
 
Figure 2: Synovitis score.  
(a) Enhanced expression of SIRT1 correlates with increased synovitis score and leukocytic 
infiltration in RA synovial tissues. (b) Synovial tissues of RA smokers show higher synovitis 
score and leukocytic infiltration than the synovial tissues of RA non smokers. *= p<0.05 as 
measured by t-test. 
 
Figure 3: Modification of SIRT1 levels induces global changes in the gene expression in 
RASF.  
Levels of SIRT1 were decreased by SIRT1 silencing or increased by transfection with SIRT1 
specific vector in RASF (n=2). Changes in the global gene expression were measured by 
poly-A-enriched transcriptome sequencing. (a) Genes that were down regulated after 
overexpression of SIRT1 and up regulated after silencing of SIRT1. (b) Genes that were up 
regulated by SIRT1 overexpression and down regulated by silencing of SIRT1.   
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Figure 4: Modification of SIRT1 levels induces changes in the gene expression in RASF.  
Levels of SIRT1 were decreased by SIRT1 silencing or increased by transfection with SIRT1 
specific vector in RASF (n=4-10). Silencing of SIRT1 significantly increased the expression 
of CDH4 (a) whereas overexpression of SIRT1 enhanced the levels of CX3CL1 (b) and JunB 
(c). *p<0.04 as determined by Wilcoxon signed rank test. 
 
Figure 5: Effect of SIRT1 silencing of rate of adhesion in RASF.  
The expression of SIRT1 was down regulated by transfection of RASF with SIRT1 specific 
siRNA for 72h. Cells were seeded in E-plates and the rate of adhesion was determined by 
analysing the slope of the curves in the first 60 minutes after seeding of the cells in real-time 
using the xCELLigence RTCA system. (a) Silencing of SIRT1 (black line) altered the rate of 
adhesion in 3 patients as compared to control transfected cells (grey line), whereas no effect 
of SIRT1 silencing on adhesion was observed in 2 patients (b). Taking all patients together, 
no significant changes in the rate of adhesion upon SIRT1 silencing were detected (c). (d) 
Significantly less PBMCs attached to SIRT1 silenced RASF compared to control transfected 
RASF after 1h of co-incubation. Representative pictures of 1 out of 6 experiments are shown. 
*p<0.04 as determined by Wilcoxon signed rank test. 
 
Figure 6: Silencing of SIRT1 decreases rate of proliferation in RASF.  
For silencing of SIRT1 RASF were transfected with SIRT1 siRNA (black line) or control 
siRNA (grey line) and seeded directly in E-plates. The graphs show dynamics and rate of 
proliferation in RASF in one representative experiment(a, ). The rate of proliferation was 
monitored in real-time using the xCELLigence RTCA system and was determined by 
analysing of the slope of the curves between 40 and 85 hours (n=5) (b). PCNA levels were 
measured after 72h of transfection with siRNA against SIRT1 or scrambled control (n=7) (c). 
** = p<0.01, ***=p<0.001 as measured by t-test. 
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Supplementary figure 1: Verification of silencing and overexpression of SIRT1.  
Expression of SIRT1 was silenced by transfection of RASF with SIRT1 (S1) specific siRNA 
or control (co) siRNA and up regulated by transfection of RASF with SIRT1 overexpression 
vector or control vector for 72h. Efficacy of silencing or overexpression was verified by Real-
time PCR (a) or Western blot analysis (b). *p<0.04 as determined by Wilcoxon signed rank 
test. 
